Navigation Links
Delcath Announces Fiscal 2011 Third Quarter Results and Recent Developments
Date:11/7/2011

NEW YORK, Nov. 7, 2011 /PRNewswire/ -- Delcath Systems (NASDAQ: DCTH) today reported financial results for the fiscal 2011 third quarter ended September 30, 2011.  Highlights for the quarter and recent developments include:

  • Research & Development:  Accelerated development of Generation Two of the Delcath Hepatic CHEMOSAT® Delivery system, which has demonstrated significantly higher filtration efficiency of melphalan in pre-clinical testing compared to Generation One of the system.
  • European Commercialization: Submission of CE Mark application for high-efficiency filter of Generation Two CHEMOSAT system, and earlier than anticipated availability of Generation Two for initial launch in European markets in early Q1 2012, subject to CE Mark approval.
  • Establishment of European Business Entity & Headquarters: Formation of Delcath Systems Ltd. (Delcath Limited), an Irish company headquartered in Galway, Ireland, under which Delcath will conduct its European operations. Delcath Limited received a development grant from IDA Ireland to support the hiring of staff over the next three years.
  • U.S. Regulatory:  Pre-New Drug Application (NDA) meeting scheduled with U.S. Food and Drug Administration (FDA) for mid-January 2012.
  • International Regulatory:  Completion of product notification process for CHEMOSAT with the Medicines and Medical Device Safety Authority in New Zealand, and submission of applications to obtain regulatory approval for CHEMOSAT for several other markets including Australia, Singapore and Hong Kong. The Company also submitted an application to obtain European CE Mark approval for the Generation Two high efficiency filter.
  • Clinical Trial Data Update: Updated efficacy results from the Company's Phase 3 trial showed the potential for CHEMOSAT as a promising
    '/>"/>

  • SOURCE Delcath Systems, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Delcath Systems to Report Third Quarter Progress and Conduct Conference Call
    2. FDA Schedules Delcath Pre-New Drug Application Meeting Date
    3. Delcath Announces Completion of Regulatory Notification Process in New Zealand
    4. Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
    5. Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011
    6. Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting
    7. Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System
    8. Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System
    9. Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011
    10. Delcath Systems to Report Second Quarter Progress Update and Conduct Conference Call
    11. Delcath Systems, Inc. Announces the Completion of Common Stock Offering
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... , Jan. 22, 2015  ViewRay™, a privately held medical ... an exclusive distributor agreement with ITOCHU Corporation (Tokyo Stock ... system for the treatment of cancer in ... is the world,s first and only MRI-guided radiation therapy ...
    (Date:1/22/2015)... Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty ... disease and overall health is pleased to provide you with ... outlook for 2015 from the CEO, Mr. Eugene Bortoluzzi ... like to take this opportunity to share with you the ...
    (Date:1/22/2015)... 2015 Increasing sophistication among enterprise buyers of language ... in 2015, says Moravia CMO, Renato ... by market research firm Common Sense Advisory, 15 percent ... translation and localization needs. "From a language industry perspective, ...
    Breaking Medicine Technology:ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
    ... Feb. 28, 2011 PolyOne Corporation (NYSE: POL ... in SunBelt Chlor Alkali Partnership to Olin Corporation.   ... venture formed in 1996 between PolyOne (formerly The Geon Company) ... for $175 million, including $132 million in cash and the ...
    ... LOUIS, Feb. 28, 2011 Stereotaxis, Inc. (Nasdaq: ... full year and fourth quarter ended December 31, 2010. ... capital orders, record recurring revenue and record gross margins. ... the year, which helped to drive decreases in both ...
    Cached Medicine Technology:PolyOne Announces Sale of SunBelt Investment 2PolyOne Announces Sale of SunBelt Investment 3Stereotaxis Reports 2010 Financial Results, Provides 2011 Financial Outlook 2Stereotaxis Reports 2010 Financial Results, Provides 2011 Financial Outlook 3Stereotaxis Reports 2010 Financial Results, Provides 2011 Financial Outlook 4Stereotaxis Reports 2010 Financial Results, Provides 2011 Financial Outlook 5Stereotaxis Reports 2010 Financial Results, Provides 2011 Financial Outlook 6Stereotaxis Reports 2010 Financial Results, Provides 2011 Financial Outlook 7
    (Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort ... as the number one best large hotel for families in ... for their annual Travelers’ Choice Awards. , TripAdvisor represents ... is home to millions of unbiased and honest traveler reviews. ...
    (Date:1/22/2015)... The Incredible Bulk is a revolutionary method ... lean muscle by up to 30lbs in less than 12 ... HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , “Our ... scientific diet formula that allows the body to pack on ...
    (Date:1/22/2015)... The federal court overseeing thousands of vaginal ... Southern District of West Virginia has upheld a $2 million ... bellwether trial. In an Order dated January 21st, the Court ... that C.R. Bard had not proven a miscarriage of justice. ...
    (Date:1/22/2015)... released a new blog post explaining the main features of ... Auto insurance quotes help many drivers find the best coverage ... an agent or visit an agency for price information. These ... http://autocarinsurancebest.com/ . , Every business who relies heavily on transportation ...
    (Date:1/22/2015)... January 22, 2015 A study ... Medicine flagship journal Medicine & Science in Sports ... exercise may help reduce gastrointestinal (GI) problems associated ... , Participants in the double-blind, placebo-controlled study took ...
    Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
    ... National,Organization of Life & Health Insurance Guaranty Associations ... that are playing,a central role in the resolution ... of New York (ELNY) matter., NOLHGA President ... ELNY situation: "NOLHGA and all of our member ...
    ... bleeding risk for patients undergoing bypass, study finds , , ... of anticlotting drug is safe over the long run ... , The drug, a "direct thrombin inhibitor" called bivalirudin, ... procedures such as bypass surgery. , "We had a ...
    ... to outlive folks who aren,t, study finds , , TUESDAY, Dec. ... life, a new study suggests fit is where it,s at ... who were physically fit outlived their contemporaries -- even thin ... fitness is a strong determinate of mortality in older men ...
    ... BMIs experience a significant survival benefit from liver ... transplant compared to patients with normal BMI. Therefore, ... listed for transplantation, say the authors of a ... a journal by John Wiley & Sons. The ...
    ... New Orleans residents in months after the disaster, study found ... people living in New Orleans and about one-quarter of those ... of a mood or anxiety disorder five to seven months ... surveyed 1,043 residents in Louisiana, Alabama and Mississippi. , They ...
    ... 3 LIVES or PROVIDE A LIFETIME OF, CLEAN, ... simple., NEW YORK, Dec. 4 This December, TONIC ... T-Shirts, designed,by guest designers., TONIC is a refreshing company ... planet through offering services and,products. Each is designed to aid ...
    Cached Medicine News:Health News:Statement on Executive Life of New York Matter 2Health News:Newer Anticlotting Drug Safe, Effective for Heart Surgeries 2Health News:Newer Anticlotting Drug Safe, Effective for Heart Surgeries 3Health News:Fitness, Not Fatness, Predicts a Longer Life 2Health News:Liver transplant offers survival benefits for patients of all sizes 2Health News:Liver transplant offers survival benefits for patients of all sizes 3Health News:Many Katrina Survivors Suffered Psychological Symptoms 2Health News:TONIC Announces Every T Counts Project 2Health News:TONIC Announces Every T Counts Project 3
    ...
    ...
    Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components...
    ... The Consensus knee system continues the ... intelligent engineering with the diversified experience of ... an affordable knee system that incorporates state-of-the-art ... provide both joint and implant stability and ...
    Medicine Products: